- Home
- KRNY vs ETON Comparison
KRNY vs ETON Comparison
Compare KRNY & ETON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | KRNY | ETON |
|---|---|---|
| Founded | 1884 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Savings Institutions | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 494.5M | 411.9M |
| IPO Year | 2005 | 2018 |
Fundamental Metrics
Financial Performance| Metric | KRNY | ETON |
|---|---|---|
| Price | $7.73 | $15.29 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 3 |
| Target Price | $8.00 | ★ $29.67 |
| AVG Volume (30 Days) | ★ 432.5K | 210.4K |
| Earning Date | 01-22-2026 | 03-17-2026 |
| Dividend Yield | ★ 5.79% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.52 | N/A |
| Revenue | ★ $163,893,000.00 | $70,316,000.00 |
| Revenue This Year | $9.70 | $107.23 |
| Revenue Next Year | $15.22 | $29.72 |
| P/E Ratio | $14.72 | ★ N/A |
| Revenue Growth | 10.69 | ★ 102.77 |
| 52 Week Low | $5.45 | $11.09 |
| 52 Week High | $8.50 | $23.00 |
Technical Indicators
Market Signals| Indicator | KRNY | ETON |
|---|---|---|
| Relative Strength Index (RSI) | 52.61 | 43.90 |
| Support Level | $7.53 | $14.62 |
| Resistance Level | $8.50 | $15.62 |
| Average True Range (ATR) | 0.24 | 0.61 |
| MACD | -0.04 | -0.03 |
| Stochastic Oscillator | 22.56 | 36.32 |
Price Performance
Historical ComparisonAbout KRNY Kearny Financial Corp
Kearny Financial Corp is a federally-chartered stock savings bank. The bank is engaged in the business of attracting deposits from the general public in New Jersey and New York, and using these deposits, together with other funds, to originate or purchase loans for its portfolios and invest in securities. The bank's loan portfolio is chiefly comprised of loans collateralized by commercial and residential real estate. The bank's primary source of income is net interest income.
About ETON Eton Pharmaceuticals Inc.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.